Abbvie Imbruvica Top 9 KOL Meal Payments on the East Coast
July 14, 2020
By: Stephen
Today we are going to look at the company AbbVie to see the most active Key Opinion Leaders (KOL) for the RX product Imbruvica. We will be using data provided by the 2018 Sunshine Act / Open Payments.
AbbVie combines advanced science to solve health issues. Imbruvica is one of AbbVie’s top products that focuses on targeted therapies. Imbruvica has generated 3.6 Billion in global sales and is very popular in the Oncology community.
In today's SpeakerBook Key Opinion Leader search we are going to look for the most active AbbVie KOL on the East Coast. The SpeakerBook meals search shows all the KOLs that have interacted with the company AbbVie. We will use SpeakerBook meals filter to research KOLs in the states of New York, Connecticut, New Jersey, Pennsylvania, and Rhode Island.
Abbvie Imbruvica top 9 KOL Meal Payments on the East Coast by SpeakerBook.
- Cyrus M Khan - $1,248
Pennsylvania
- Michael W Schuster - $979
New York
- Perry C Cook - $776
New York
- Delong Liu - $444
New York
- Ariela Noy - $353
New York
- Michael Krabak - $324
New York
- Anthony R Mato - $303
Pennsylvania
- Nicole Lamanna - $295
New York
- Carmelo A Puccio - $249
New York
SpeakerBook KOL generator shows Cyrus M Khan from Pennsylvania as the most active Abbvie Imbruvica KOL for meal payments on the east coast. Cyrus has taken $277,007 in payments from Pharma companies in the industry with Imbruvica from AbbVie making up 23% of those payments.
Dr. Cyrus M Khan is a Hematology / Oncology Specialist in Pittsburgh, Pennsylvania. We can use SpeakerBook to see how often Cyrus is interacting with AbbVie, when those interactions are taking place, and how much the payments were per interaction.
SpeakerBook shows that Cyrus M Khan's most active speaking month was May. In May 2018 Cyrus had 13 speaking engagements. Some of the companies Cyrus spoke for include Seattle Genetics, Janssen Biotech, Gilead Sciences, Celgene, Genentech, and Pharmacyclics. The payments for Cyrus speaking fees in May 2018 were $42960. Cyrus spent a total of 12 days out of the month speaking with only one day of overlap where he spoke twice on the same day for the company Celgene on the product Revlimid.
Any Pharma sales rep can now look into the other pharmaceutical companies and products associated with Cyrus’s total payments to view other active KOLs discussing the same products as Cyrus.
As an example we can look at all the meal payments to see that Cyrus has also had discussions on the products Gazyva, Tasigna, Zydelig, Calquence, Ninlaro, and Soliris to name a few.
You can note any dates or speaking engagements with the SpeakerBook CRM notes tool. Document valuable information in Cyrus’s SpeakerBook notes section.
The second most active AbbVie Imbruvica KOL is Michael W Schuster from New York. Dr. Michael W. Schuster is an oncologist in Stony Brook, New York and is affiliated with multiple hospitals in the area. Michael has received over $317,219 payments from pharmaceutical companies in 2018 with Imbruvica making up 13% or around $40,000 of his total payments.
Let's look at some of Michael's speaking dates. The SpeakerBook total payments page shows that Michael is a very active summer speaker with 28 speaking events in the summer months of 2018. Some of the products Michael discussed included Cresemba, Tasigna, Adcetris, Blincyto, Imbruvica, and Gazyva. Unlike Cyrus Michael seems to group his speaking dates together over the course of the same day. This most likely means these speaking events are multi day conferences.
Michael's meal payments show all day events with companies Janssen Biotech and Gilead Sciences in the month of April 2018.
You can use SpeakerBook to research any KOL in the Pharma industry. SpeakerBook helps Pharma sales reps locate top KOLs. After the most active KOLs are located you can use SpeakerBook as a pre-call planning template to keep up to date notes on every KOL in the USA. Download The SpeakerBook App Today